Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
25.87
+0.60 (2.37%)
At close: Sep 10, 2025, 4:00 PM
25.67
-0.20 (-0.78%)
After-hours: Sep 10, 2025, 6:45 PM EDT
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$4,765,194
Market Cap
2.91B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 36 | 9 | 33.33% |
Dec 31, 2023 | 27 | 6 | 28.57% |
Dec 31, 2022 | 21 | 3 | 16.67% |
Dec 31, 2021 | 18 | -2 | -10.00% |
Dec 31, 2020 | 20 | 1 | 5.26% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VKTX News
- 2 days ago - Viking Therapeutics, Inc. (VKTX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 13 days ago - Viking Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 18 days ago - Viking: Still On Track, But The Compass Needs Recalibration - Seeking Alpha
- 20 days ago - Viking Therapeutics: Panic Creates Opportunity - Seeking Alpha
- 21 days ago - Viking Therapeutics: What's Happening With VKTX Stock? - Forbes
- 21 days ago - Why Viking Therapeutics stock reaction to obesity pill data is wildly ‘overdone' - Invezz
- 22 days ago - Viking Obesity Pill Faces Steep Climb Against Lilly's Tirzepatide, Analyst Calls Downtrend Reaction 'Extreme' - Benzinga
- 22 days ago - Viking Therapeutics Stock Plunges on Oral Weight-Loss Pill Study Results - Investopedia